Valneva says Chikungunya vaccine phase-III trial has met primary endpoint Reuters Dec 23, 2021 In August, after Valneva gave a positive update on the phase-III trial
IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica EP News Bureau Aug 25, 2021 IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…
Themis Bioscience appoints Dr Philippe Dro and Dr Christian Mandl EP News Bureau Feb 4, 2016 The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine
